Imbruvica, Drug to Treat Blood Cancer, Gains F.D.A. Approval
Thursday, November 14, 2013 - 16:51
in Health & Medicine
The drug has been approved by the Food and Drug Administration to treat relapses of a rare blood cancer called mantle cell lymphoma.